TRPC6 and focal segmental glomerulosclerosis: While we cannot exclude a role for TRPC6 in immunomodulation in PAN nephrosis, FSGS is generally considered to be a podocyte disease, and there is a report that podocyte-specific over-expression of TRPC6 results in glomerular disease in mice [16].